Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
INMD | US
0.04
0.28%
Healthcare
Medical Devices
30/06/2024
24/04/2026
14.40
14.41
14.41
14.19
InMode Ltd. designs develops manufactures and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures such as liposuction with simultaneous skin tightening body and face contouring and ablative skin rejuvenation treatments as well as for use in women's health conditions and procedures. It also designs develops manufactures and markets non-invasive medical aesthetic products that target an array of procedures including permanent hair reduction facial skin rejuvenation wrinkle reduction cellulite treatment skin appearance and texture and superficial benign vascular and pigmented lesions as well as hands-free medical aesthetic products that target a range of procedures such as skin tightening fat reduction and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam Israel.
View LessValue Stock (Price to Book < 3)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
21.7%1 month
19.9%3 months
41.8%6 months
35.5%10.28
8.50
1.75
-
-
4.37
1.41
2.90
134.65M
1.10B
1.10B
-
21.18
-56.90
-36.50
21.05
6.42
9.88
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.49
Range1M
1.63
Range3M
3.95
Rel. volume
0.52
Price X volume
5.47M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CONMED Corporation | CNMD | Medical Devices | 38.34 | 1.18B | 2.24% | 21.14 | 109.53% |
| Butterfly Network Inc. | BFLY | Medical Devices | 5.33 | 1.13B | 3.50% | n/a | 12.34% |
| IRadimed Corporation | IRMD | Medical Devices | 88.68 | 1.12B | -0.14% | 35.49 | 0.47% |
| BioLife Solutions Inc | BLFS | Medical Instruments & Supplies | 21.38 | 986.43M | -1.57% | n/a | 11.19% |
| Integra LifeSciences Holdings Corporation | IART | Medical Devices | 10.57 | 820.04M | 2.42% | 68.52 | 130.98% |
| Bioventus Inc. | BVS | Medical Devices | 10.09 | 657.74M | 3.91% | n/a | 261.56% |
| Tactile Systems Technology Inc | TCMD | Medical Devices | 25.07 | 600.85M | 2.54% | 10.39 | 23.72% |
| Cytek Biosciences Inc. Common Stock | CTKB | Medical Devices | 4.4 | 578.63M | 3.29% | n/a | 8.53% |
| SI-BONE Inc | SIBN | Medical Devices | 13.52 | 563.70M | 0.90% | n/a | 24.28% |
| Embecta Corp | EMBC | Medical Instruments & Supplies | 9.22 | 532.01M | 0.77% | 11.37 | -216.41% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Marcus & Millichap Inc | MMI | Real Estate Services | 28.26 | 1.09B | 1.11% | n/a | 14.11% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.44 | 790.55M | 1.30% | 11.62 | 116.21% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.01 | 694.62M | -0.17% | 65.18 | 77.00% |
| Comstock Mining Inc | LODE | Real Estate Services | 3.25 | 671.56M | -0.31% | 6.38 | 14.37% |
| The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 2.68 | 529.98M | 2.68% | n/a | 0.00% |
| Ennis Inc | EBF | Building Products & Equipment | 20.33 | 528.66M | -1.26% | 13.28 | 2.28% |
| FRP Holdings Inc | FRPH | Real Estate Services | 21.59 | 410.87M | 0.89% | 75.50 | 42.65% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.31 | 317.09M | 1.85% | n/a | 174.23% |
| The RMR Group Inc | RMR | Real Estate Services | 16.96 | 283.65M | 1.37% | 16.64 | 14.14% |
| Urban One Inc | UONEK | Broadcasting - Radio | 4.9543 | 262.62M | -0.42% | n/a | 268.43% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 4.37 | 46.09 | Cheaper |
| Ent. to Revenue | 1.41 | 14.34 | Cheaper |
| PE Ratio | 10.28 | 30.41 | Cheaper |
| Price to Book | 1.75 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 41.80 | 64.12 | Lower Risk |
| Debt to Equity | - | -145.53 | - |
| Debt to Assets | - | 0.35 | - |
| Market Cap | 1.10B | 9.70B | Emerging |